#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15678	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2128	727.6	0	.	n	.	0	C451T	SNP	451	451	C	641	641	T	936	T,C	882,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15678	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2128	727.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1374	1374	C	899	C,G	845,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15678	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2128	727.6	0	HET	.	.	.	C207T,G	.	207	207	C	397	397	C	889	C,T,G	660,157,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28558	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3381	837.2	0	.	n	.	0	T695C	SNP	695	695	T	941	941	C	874	C,A	816,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28558	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3381	837.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2217	2217	C	886	C	825	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28558	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3381	837.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2291	2291	A	846	A	804	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28558	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3381	837.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2843	2843	C	867	C	816	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1870	folP	855	855	100.0	folP.l15.c30.ctg.1	1668	111.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1021	1023	AGC	200;200;199	A;G;C	190;188;183	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3447	158.1	1	SNP	p	S91F	1	.	.	271	273	TTC	569	571	TTC	216;218;220	T;T;C	200;202;202	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3447	158.1	1	SNP	p	D95G	1	.	.	283	285	GGC	581	583	GGC	217;214;213	G;G;C	204;198;199	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5472	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3447	158.1	1	SNP	p	G95N	0	.	.	283	285	GGC	581	583	GGC	217;214;213	G;G;C	204;198;199	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1468	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1389	104.9	1	SNP	p	G45D	0	.	.	133	135	GGC	454	456	GGC	190;187;188	G;G;C	173;167;174	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	816	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1138	71.4	0	.	n	.	0	A197.	DEL	197	197	A	659	659	A	191	A	181	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5922	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	201.2	1	SNP	p	D86N	0	.	.	256	258	GAC	554	556	GAC	261;260;259	G;A,G;C,T	237;229,1;234,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5922	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	201.2	1	SNP	p	R87W	0	.	.	259	261	CGT	557	559	CGT	260;252;251	C,T;G;T,C	238,1;231;221,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5922	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	201.2	1	SNP	p	R87I	0	.	.	259	261	CGT	557	559	CGT	260;252;251	C,T;G;T,C	238,1;231;221,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5922	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	201.2	1	SNP	p	S87R	1	.	.	259	261	CGT	557	559	CGT	260;252;251	C,T;G;T,C	238,1;231;221,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5922	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2923	201.2	1	SNP	p	S88P	0	.	.	262	264	TCC	560	562	TCC	249;249;250	T;C;C	227;231;230	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4066	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2704	149.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1560	1562	GGC	164;163;163	G;G;C	148;145;147	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1226	1228	GCC	224;224;223	G;C;C	211;213;213	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1229	1231	ATG	224;225;226	A;T;G	213;214;212	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1241	1243	ACC	220;219;219	A;C;C	209;209;209	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1241	1243	ACC	220;219;219	A;C;C	209;209;209	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1742	1744	ACC	201;203;202	A;C;C	182;192;194	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1796	1798	GCG	203;203;203	G;C;G	193;193;192	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1796	1798	GCG	203;203;203	G;C;G	193;193;192	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1919	1921	GGT	142;143;144	G;G;T	135;138;137	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1928	1930	AGC	143;144;143	A;G;C	133;135;134	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4066	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	170.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1946	1948	CCG	129;133;130	C,G;C,G;G	96,6;100,1;95	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6104	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3002	201.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1576	1578	CCG	201;200;193	C;C;G	174;183;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2268	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1852	121.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	588	588	C	169	C,T	154,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3214	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1606	198.4	0	.	p	.	0	S255N	NONSYN	763	765	AGC	1053	1055	AAC	271;272;273	A;A;C	262;260;261	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3214	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1606	198.4	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	256;252;250	A,C;A;G	237,1;237;231	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3214	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1606	198.4	1	SNP	p	A121N	1	.	.	361	363	AAC	651	653	AAC	251;248;249	A;A;C	234;234;231	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3214	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1606	198.4	1	SNP	p	N121D	0	.	.	361	363	AAC	651	653	AAC	251;248;249	A;A;C	234;234;231	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12322	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4884	250.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1288	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1031	124.0	1	SNP	p	V57M	1	.	.	169	171	ATG	594	596	ATG	262;260;260	A;T;G	246;244;245	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
